**8. Conclusion**

BC continues to be cancer with the highest number of cases and deaths worldwide. While the TNBC subtype is characterized by a worse prognosis, due to high rates of recurrences and metastasis, there is no standardized treatment so far, reasons that call the attention of researchers to find new therapeutic proposals. Thus, noting that several integrins are overexpressed during the progression of BC; disintegrins have pharmacological potential as a new alternative in cancer.
